Otsuka’s ADHD drug reduces symptoms in Phase IIIb trial
Source: news.google.com
Published: Jun 25, 2026 14:32
Source: news.google.com
Published: Jun 25, 2026 14:32
Related Stories
Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning The New York Times
#Clinical TrialsJoseph Gomes, MD, Recognized by Marquis Who's Who for Leadership in Medical Innovation Yahoo Finance
#Health InnovationBIO Notebook: Big Pharmas Help With Entrances; Biotech M&A Offers Exits Citeline News & Insights
#Biotech Headlines‘Too Good to Be True:’ A Chinese Study on Timing Cancer Therapy Is Retracted The New York Times
#Clinical TrialsBIO 2026: FDA Leadership Confront Workforce Losses, China Competition in Drug Development Genetic Engineering and Biotechnology News
#Biotech HeadlinesFDA OKs first human trial of oral MS remyelination therapy PTD802 Multiple Sclerosis News Today
#Clinical TrialsAdd Shortcut
Open this site faster like an app from your phone home screen.